Use of Platelet-Rich Plasma (PRP) Injections to Improve Knee Pain and Function Among Patients with Osteoarthritis

Principal Investigator:

Dr. Grant Pagdin

MD, University of British Columbia

Canadian board-certified in Family Medicine, American Academy of Anti-Aging and Regenerative Medicine (ABAARM).  Fellowship in Family Medicine (FCFP).  Fellowship in Stem Cell Medicine.  Fellow with the Interventional Orthobiologics Foundation.

Study Abstract:

This Circle unites orthopedists from around the world in the evidence-based standardization of effectiveness and safety of PRP injections for Knee OA.  Over a 12-month period, this Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of PRP. The Circle also collects clinically pertinent data including PRP type and knee injection administration route, providing valuable insights for clinical decision-making.

Study Type:

Interventional, Quality Improvement

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.
  • Drive superior patient education and engagement.
  • Legal/regulatory compliance.
  • Support payer negotiations.
Real-World Data Surveys:
  • Visual Analogue Scale (VAS)
  • Western Ontario and McMaster Universities Arthritis Index (WOMAC)
  • Sleep Condition Indicator (SCI)
Circle Type:
locked lock icon for private circles

Private Circle

Interested in learning more about this Circle?

Related Posts

No items found.
Additional Resources:

Use of Platelet-Rich Plasma (PRP) Injections to Improve Knee Pain and Function Among Patients with Osteoarthritis

Circle Objective Abstract:

This Circle unites orthopedists from around the world in the evidence-based standardization of effectiveness and safety of PRP injections for Knee OA.  Over a 12-month period, this Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of PRP. The Circle also collects clinically pertinent data including PRP type and knee injection administration route, providing valuable insights for clinical decision-making.

This Circle unites orthopedists from around the world in the evidence-based standardization of Effectiveness and Safety of PRP Injection in Knee OA

Real-World Data Surveys:

VAS, WOMAC, SCI

Intervention:

PRP

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.
  • Drive superior patient education and engagement.
  • Legal/regulatory compliance.
  • Support payer negotiations.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:
locked lock icon for private circles

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES